Davion Healthcare Plc. (NASDAQ:DAVI – Get Free Report) saw a significant growth in short interest during the month of October. As of October 30th, there was short interest totaling 617,708 shares. Based on an average daily trading volume, of 1,928,918 shares, the short-interest ratio is presently 0.3 days. Approximately 2.5% of the company’s stock are short sold.
Analyst Ratings Changes
Separately, Wall Street Zen upgraded Davion Healthcare to a “hold” rating in a research note on Saturday, October 31st.
Check Out Our Latest Research Report on Davion Healthcare
Davion Healthcare Stock Performance
Shares of DAVI stock opened at $1.02 on Tuesday. Davion Healthcare has a 12 month low of $0.91 and a 12 month high of $12.30.
Davion Healthcare Company Profile
Davion Healthcare Plc is a digital healthcare company developing proprietary, non-invasive health monitoring technologies designed to support the early identification of medical anomalies outside traditional clinical environments. The Company’s flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. Davion Healthcare Plc is based in DUBLIN.
See Also
- Five stocks we like better than Davion Healthcare
- MongoDB’s Biggest Advantage May Be GitLab’s Biggest Weakness
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
Receive News & Ratings for Davion Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davion Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
